MOUNT LAUREL, N.J., June 14, 2011 /PRNewswire/ — ImpactRx, the
pioneer in measuring the impact of promotion on physician
prescribing behavior announced today that it has expanded its
nationwide network of high-value, iPhone-connected physicians.
ImpactRx now has access to 175 adult psychiatrists as well as
to a new panel of 150 adolescent psychiatrists. This
expansion enables ImpactRx to better serve the growing neuroscience
category, in particular the important ADD/ADHD market, and to more
effectively support the needs of its pharmaceutical and biotech
clients.
“As the competition increases for face-to-face promotional time
with psychiatrists, so does the need for effective tracking,
evaluating and reporting the effect of promotional activities on
prescribing behavior,” says Richard Altus, President and CEO of
ImpactRx. “Our proprietary network of high-value,
iPhone-connected psychiatrists continuously captures feedback in
real-time, providing our clients a closer view of the relationship
between prescribing decisions and influencing metrics such as
promotional activity, sales representative effectiveness and
marketplace dynamics. The ImpactData™ will provide our
clients with an analytic and strategic edge as well as a better
understanding of the psychiatric marketplace as a whole.”
ImpactRx’s fourteen physician specialty panels include Primary
Care, Oncology, Endocrinology, Pulmonology and Neurology. The
expansion of the psychiatry panels strengthens the comprehensive
and customizable brand and marketing research solutions offered by
ImpactRx.
About ImpactRx
Founded in 2000 and headquartered in Mount Laurel, N.J.,
ImpactRx’s longitudinal panels of high value, iPhone-connected
physicians are the exclusive source of continuously-captured
promotion and treatment data. Through its proprietary methodology,
the Company annually captures one million details and three-million
treatment deci
‘/>”/>